BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 1433500)

  • 1. Sulfation of the human immunodeficiency virus envelope glycoprotein.
    Bernstein HB; Compans RW
    J Virol; 1992 Dec; 66(12):6953-9. PubMed ID: 1433500
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of endoproteolytic cleavage and intracellular transport of human immunodeficiency virus type 1 envelope glycoproteins using mutant CD4 molecules bearing the transmembrane endoplasmic reticulum retention signal.
    Raja NU; Vincent MJ; Jabbar MA
    J Gen Virol; 1993 Oct; 74 ( Pt 10)():2085-97. PubMed ID: 8409933
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Complex-type N-linked oligosaccharides of gp120 from human immunodeficiency virus type 1 contain sulfated N-acetylglucosamine.
    Shilatifard A; Merkle RK; Helland DE; Welles JL; Haseltine WA; Cummings RD
    J Virol; 1993 Feb; 67(2):943-52. PubMed ID: 8419650
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional role of the glycan cluster of the human immunodeficiency virus type 1 transmembrane glycoprotein (gp41) ectodomain.
    Fenouillet E; Jones I; Powell B; Schmitt D; Kieny MP; Gluckman JC
    J Virol; 1993 Jan; 67(1):150-60. PubMed ID: 8093218
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The glycosylation of human immunodeficiency virus type 1 transmembrane glycoprotein (gp41) is important for the efficient intracellular transport of the envelope precursor gp160.
    Fenouillet E; Jones IM
    J Gen Virol; 1995 Jun; 76 ( Pt 6)():1509-14. PubMed ID: 7782780
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced proteolytic processing of the human immunodeficiency virus type 1 envelope protein in murine Ltk(-) cells.
    Rodriguez D; Rodriguez JR; Esteban M
    AIDS Res Hum Retroviruses; 1995 Jan; 11(1):81-5. PubMed ID: 7734199
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Envelope glycoprotein incorporation, not shedding of surface envelope glycoprotein (gp120/SU), Is the primary determinant of SU content of purified human immunodeficiency virus type 1 and simian immunodeficiency virus.
    Chertova E; Bess JW; Crise BJ; Sowder II RC; Schaden TM; Hilburn JM; Hoxie JA; Benveniste RE; Lifson JD; Henderson LE; Arthur LO
    J Virol; 2002 Jun; 76(11):5315-25. PubMed ID: 11991960
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The convertases furin and PC1 can both cleave the human immunodeficiency virus (HIV)-1 envelope glycoprotein gp160 into gp120 (HIV-1 SU) and gp41 (HIV-I TM).
    Decroly E; Vandenbranden M; Ruysschaert JM; Cogniaux J; Jacob GS; Howard SC; Marshall G; Kompelli A; Basak A; Jean F
    J Biol Chem; 1994 Apr; 269(16):12240-7. PubMed ID: 8163529
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stable expression of the human immunodeficiency virus type 1 envelope glycoprotein in transfected L cells.
    Bird C; Gleeson PA; Ramsay A; Li P; McCluskey J
    AIDS Res Hum Retroviruses; 1992 Dec; 8(12):1999-2009. PubMed ID: 1493050
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The human and simian immunodeficiency virus envelope glycoprotein transmembrane subunits are palmitoylated.
    Yang C; Spies CP; Compans RW
    Proc Natl Acad Sci U S A; 1995 Oct; 92(21):9871-5. PubMed ID: 7568235
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Brefeldin A inhibits the processing and secretion of envelope glycoproteins of human immunodeficiency virus type 1.
    Pal R; Mumbauer S; Hoke GM; Takatsuki A; Sarngadharan MG
    AIDS Res Hum Retroviruses; 1991 Aug; 7(8):707-12. PubMed ID: 1718346
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vaccinia virus vectors for study of membrane fusion mediated by human immunodeficiency virus envelope glycoprotein and CD4.
    Ashorn P; Berger EA; Moss B
    Methods Enzymol; 1993; 221():12-8. PubMed ID: 8361369
    [No Abstract]   [Full Text] [Related]  

  • 13. Conformational changes induced in the envelope glycoproteins of the human and simian immunodeficiency viruses by soluble receptor binding.
    Sattentau QJ; Moore JP; Vignaux F; Traincard F; Poignard P
    J Virol; 1993 Dec; 67(12):7383-93. PubMed ID: 7693970
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alternate pathways of secretion of simian immunodeficiency virus envelope glycoproteins.
    Spies CP; Compans RW
    J Virol; 1993 Nov; 67(11):6535-41. PubMed ID: 8411356
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased incorporation of chimeric human immunodeficiency virus type 1 gp120 proteins into Pr55gag virus-like particles by an Epstein-Barr virus gp220/350-derived transmembrane domain.
    Deml L; Kratochwil G; Osterrieder N; Knüchel R; Wolf H; Wagner R
    Virology; 1997 Aug; 235(1):10-25. PubMed ID: 9300033
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of stable Chinese hamster ovary cells expressing wild-type, secreted, and glycosylphosphatidylinositol-anchored human immunodeficiency virus type 1 envelope glycoprotein.
    Weiss CD; White JM
    J Virol; 1993 Dec; 67(12):7060-6. PubMed ID: 8230430
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The human immunodeficiency virus type 1 envelope glycoprotein precursor acquires aberrant intermolecular disulfide bonds that may prevent normal proteolytic processing.
    Owens RJ; Compans RW
    Virology; 1990 Dec; 179(2):827-33. PubMed ID: 2238472
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Normal T cell receptor-mediated signaling in T cell lines stably expressing HIV-1 envelope glycoproteins.
    Tani Y; Tian H; Lane HC; Cohen DI
    J Immunol; 1993 Dec; 151(12):7337-48. PubMed ID: 7903106
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intracellular membrane traffic of human immunodeficiency virus type 1 envelope glycoproteins: vpu liberates Golgi-targeted gp160 from CD4-dependent retention in the endoplasmic reticulum.
    Kimura T; Nishikawa M; Ohyama A
    J Biochem; 1994 May; 115(5):1010-20. PubMed ID: 7961587
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of membrane anchorage domains of the HIV-1 gp160 envelope glycoprotein precursor.
    Gabuzda D; Olshevsky U; Bertani P; Haseltine WA; Sodroski J
    J Acquir Immune Defic Syndr (1988); 1991; 4(1):34-40. PubMed ID: 1984054
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.